Armand Cognetta, founder and CEO of General Proximity, joins us to explore how proximity medicine is revolutionizing drug discovery by targeting proteins once considered impossible to drug.

We discuss the evolution beyond PROTACs, being a solo bio-founder in Y Combinator, and Armand's journey from imposter syndrome to raising $16M and winning a $3M ARPA-H grant.

From nearly running out of money to building breakthrough platform technology, Armand shares hard-won lessons on fundraising, team building, and maintaining startup speed in an industry known for decade-long timelines.

Robin Roehm, CEO and co-founder of Apheris, joins us to explore how federated learning is transforming data collaboration in life sciences.

We discuss its impact on drug discovery and clinical trials, the balance between IP protection and AI innovation, and Robin’s journey at the crossroads of tech and healthcare.

Join us for a deep dive into multimodal AI data architecture with John Axerio-Cilies, Chief Data Technology Officer at Tempus AI and former CEO/CTO of Arterys.

John shares insights from building the first FDA-cleared deep learning algorithm in healthcare and now leading data integration across imaging, text, and molecular modalities at scale.